Insight Into the Recent Advancements in Thiazolidinedione Derivatives as PPAR-γ Agonists for the Treatment of Type 2 Diabetes.

Jain A, Majee C, Sharma R, Mazunder R

Open source

DOI
10.2174/0113895575484618260821093418
Published
2026 Sep 7
Container
Mini reviews in medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113895575484618260821093418,
  title = {Insight Into the Recent Advancements in Thiazolidinedione Derivatives as PPAR-γ Agonists for the Treatment of Type 2 Diabetes.},
  author = {Jain A and Majee C and Sharma R and Mazunder R},
  year = {2026},
  journal = {Mini reviews in medicinal chemistry},
  doi = {10.2174/0113895575484618260821093418},
  url = {https://doi.org/10.2174/0113895575484618260821093418}
}

RIS

TY  - JOUR
TI  - Insight Into the Recent Advancements in Thiazolidinedione Derivatives as PPAR-γ Agonists for the Treatment of Type 2 Diabetes.
AU  - Jain A
AU  - Majee C
AU  - Sharma R
AU  - Mazunder R
PY  - 2026
JO  - Mini reviews in medicinal chemistry
DO  - 10.2174/0113895575484618260821093418
UR  - https://doi.org/10.2174/0113895575484618260821093418
ER  - 

APA

A, J., C, M., R, S., & R, M. (2026). Insight Into the Recent Advancements in Thiazolidinedione Derivatives as PPAR-γ Agonists for the Treatment of Type 2 Diabetes.. Mini reviews in medicinal chemistry. https://doi.org/10.2174/0113895575484618260821093418

Source records